Please login to the form below
Ranbaxy wins FDA approval for Metformin in US
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
Ipca Laboratories, which has a strategic alliance with Ranbaxy, will manufacture the formulation at its facilities in India. Ranbaxy will commercialise the product in the US market, Ipca revealed in a press statement to the Bombay Stock Exchange.
Total annual US sales for Metformin, an insulin sensitising agent, was USD 379m, according to Ranbaxy.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Moderna to begin pivotal phase 3 trial of COVID-19 vaccine in July
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Regeneron says antibody for COVID-19 could be ready this year
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Lilly starts world first trial of an antibody drug for COVID-19
- 20 for 2020 – Five pharma companies to watch
- Hydroxychloroquine fails trial as preventative measure against COVID-19
- Four European nations form alliance to fast-track COVID-19 vaccine
- Pierre Fabre’s Braftovi gets EU okay for BRAF+ colorectal cancer
- Integrated comms in the healthcare industry
- AI and genomics: a revolution in drug discovery and development
- Great minds don’t think alike
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- AI and genomics: a revolution in drug discovery and development
- ...
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Quick links
Infographics
